VolitionRx announced that the Company achieved CE marking on its Nu Q Colorectal Cancer Screening Triage Test, paving the way...
For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery in adults (see below). Aspirin has an antithrombotic action, mediated through inhibition of platelet activation, which has been shown to be useful in secondary prophylaxis following myocardial infarction and in patients with unstable angina or ischaemic stroke including cerebral transient attacks. Nu-Seals 75 is indicated when prolonged dosage of aspirin is required. The special coating resists dissolution in gastric juice but will dissolve readily in the relatively less acid environment of the duodenum. Owing to the delay that the coating imposes on the release of the active ingredient, Nu-Seals 75 is unsuitable for the short-term relief of pain.
VolitionRx Limited a life sciences company focused on developing diagnostic tests for cancer, announced that it expects to receive CE...
Aspirin has analgesic, antipyretic and anti-inflammatory actions. It can also be used for the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery in adults (see below). Aspirin has an anti-thrombotic action, mediated through inhibition of platelet activation, which has been shown to be useful in secondary prophylaxis following myocardial infarction, and in patients with unstable angina or ischaemic stroke including cerebral transient attacks. Nu-Seals 300 is indicated wherever high and prolonged dosage of aspirin is required. The special coating resists dissolution in gastric juice but will dissolve readily in the relatively less acid environment of the duo-denum. Owing to the delay that the coating imposes on the release of the active ingredient, Nu-Seals 300 is unsuitable for the short-term relief of pain.
Analgesic sclerosing agent in the treatment of internal haemorrhoids
Arcutis Biotherapeutics, Inc. announced the launch of an educational campaign designed to elevate understanding, connection, and encouragement for those living with seborrheic dermatitis, or Seb Derm for short
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the FDA has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.
The antitumor activity of vandetanib [a multiple signal transduction inhibitor including the RET tyrosine kinase, epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF) receptor (VEGFR),...